NCT06954584 2025-06-24Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian CancerTongji HospitalPhase 3 Recruiting424 enrolled